CXCL10 and lobular neoplasia: The signaling pathway was found to be significantly enriched in LN patients through biological experiments and immunofluorescence,18,29 with high expression of the ligand CXCL10 in CB3 and the receptor CXCR3 in CT5a (Figure 2C).